Clinical Outcomes and Prognostic Factors in Eyelid Malignancy: A 17-Year Retrospective Analysis of Surgical Management and Reconstruction Techniques |
Abdulaziz S. AlHarthi1, Jungyul Park2, Suk-Woo Yang2 |
1Ophthalmology Department, College of Medicine, Majmaah University, Al-Majmaah 11952, Saudi Arabia 2Department of Ophthalmology and Visual Science, Seoul St. Mary’s Hospital, College of Medicine, the Catholic University of Korea, Seoul, Republic of Korea |
Correspondence:
Suk-Woo Yang, Email: yswoph@hanmail.net |
Received: 4 January 2024 • Revised: 1 September 2024 • Accepted: 1 October 2024 |
Abstract |
Purpose To assess clinical outcomes in patients undergoing surgical excision and eyelid reconstruction for malignancies.
Methods This 17-year retrospective study (2004–2021) analyzed patients with malignant eyelid tumors who underwent excision and reconstruction. Data on tumor type, size, location, surgical techniques, complications, and prognostic factors for recurrence were evaluated.
Result A total of 152 patients underwent surgical excision and reconstruction for eyelid malignancies. Basal cell carcinoma (52.6%) was the most common, followed by sebaceous cell carcinoma (32.2%). Direct lid closure was the most frequent reconstructive method. Postoperative complications, including ectropion, entropion, and canalicular obstruction, were minimal but required additional surgery in some cases. Recurrence occurred in 13 patients. Lymph node involvement (OR 21.291, p = 0.004) and positive intraoperative frozen margins (OR 7.083, p = 0.018) were significant risk factors for local recurrence.
Conclusion Surgical excision and reconstruction are effective treatments for eyelid malignancies, with techniques tailored to tumor size, location, and extension to ensure proper lid function. Lymph node involvement and positive intraoperative frozen margins are key predictors of local recurrence. |
Key Words:
eyelid malignancy, eyelid reconstruction, orbital exenteration, recurrence |
|